These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9861209)

  • 41. Correlation between dosimetric parameters and late rectal and urinary toxicities in patients treated with high-dose-rate brachytherapy used as monotherapy for prostate cancer.
    Konishi K; Yoshioka Y; Isohashi F; Sumida I; Kawaguchi Y; Kotsuma T; Adachi K; Morimoto M; Fukuda S; Inoue T
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1003-7. PubMed ID: 19345517
    [TBL] [Abstract][Full Text] [Related]  

  • 42. When prostate brachytherapy fails: a case report and discussion.
    Kadoch C; D'Amico AV; Matthews RH
    Oncologist; 2005; 10(10):799-805. PubMed ID: 16314290
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Subacute penile numbness after brachytherapy for prostate cancer.
    Sharp HJ; Swanson DA; Patel H; Gorbatiy V; Frenzel JC; Frank SJ
    Brachytherapy; 2011; 10(1):64-7. PubMed ID: 20685173
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessing the impact of an alternative biochemical failure definition on radiation dose response for high-risk prostate cancer treated with external beam radiotherapy.
    Cheung R; Tucker SL; Lee AL; Dong L; Kamat A; Pisters L; Kuban DA
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):14-9. PubMed ID: 15629589
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High-dose-rate brachytherapy for localized prostate adenocarcinoma post abdominoperineal resection of the rectum and pelvic irradiation: Technique and experience.
    Jabbari S; Hsu IC; Kawakami J; Weinberg VK; Speight JL; Gottschalk AR; Roach M; Shinohara K
    Brachytherapy; 2009; 8(4):339-44. PubMed ID: 19428310
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of different definitions of biochemical failure after external beam radiotherapy changes conclusions about relative treatment efficacy for localized prostate cancer.
    Kupelian PA; Mahadevan A; Reddy CA; Reuther AM; Klein EA
    Urology; 2006 Sep; 68(3):593-8. PubMed ID: 16979731
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of external radiotherapy in patients treated with permanent prostate brachytherapy.
    Potters L; Fearn P; Kattan M
    Prostate Cancer Prostatic Dis; 2002; 5(1):47-53. PubMed ID: 15195130
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prostatic carcinosarcoma 15 years after combined external beam radiation and brachytherapy for prostatic adenocarcinoma: a case report.
    Tseng TY; Sevilla DW; Moul JW; Maloney KE
    Prostate Cancer Prostatic Dis; 2006; 9(2):195-7. PubMed ID: 16568146
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Failure definition-dependent differences in outcome following radiation for localized prostate cancer: can one size fit all?
    Kuban D; Thames H; Levy L; Horwitz E; Kupelian P; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):409-14. PubMed ID: 15667960
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinoma.
    Martin JM; Rosewall T; Bayley A; Bristow R; Chung P; Crook J; Gospodarowicz M; McLean M; Ménard C; Milosevic M; Warde P; Catton C
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1084-9. PubMed ID: 17606331
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High dose rate brachytherapy as a boost for the treatment of localized prostate cancer.
    Phan TP; Syed AM; Puthawala A; Sharma A; Khan F
    J Urol; 2007 Jan; 177(1):123-7; discussion 127. PubMed ID: 17162020
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mostly for men.
    Isaacson RJ
    Angle Orthod; 2005 Jul; 75(4):694. PubMed ID: 16097243
    [No Abstract]   [Full Text] [Related]  

  • 53. PSA screening.
    Wilson JF; Hussey DH; Lawton CA; Leibel SA; Shipley WU
    J Fam Pract; 1994 Sep; 39(3):216-7. PubMed ID: 7521388
    [No Abstract]   [Full Text] [Related]  

  • 54. Practical considerations in permanent brachytherapy for localized adenocarcinoma of the prostate.
    Stone NN; Stock RG
    Urol Clin North Am; 2003 May; 30(2):351-62. PubMed ID: 12735510
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correction: Inaccurate analysis and results in a study of radiation therapy in adenocarcinoma of the prostate.
    Zietman AL
    JAMA; 2008 Feb; 299(8):898-9. PubMed ID: 18314431
    [No Abstract]   [Full Text] [Related]  

  • 56. High-dose rate brachytherapy--the Charité experience.
    Böhmer D; Deger S; Dinges S; Schnorr D; Loening SA; Budach V
    Front Radiat Ther Oncol; 2002; 36():177-82. PubMed ID: 11842750
    [No Abstract]   [Full Text] [Related]  

  • 57. [Remote afterloading transurethral radiotherapy of prostatic cancer].
    Kigure T; Harada T; Etori K; Nishizawa O; Miyagata S; Kumazaki T; Koh D; Shimoda J; Hongoh R; Tsuchida S
    Nihon Gan Chiryo Gakkai Shi; 1988 Oct; 23(10):2514-9. PubMed ID: 3209920
    [No Abstract]   [Full Text] [Related]  

  • 58. Role of radiation therapy in prostate cancer.
    Amin PP
    Prog Clin Biol Res; 1988; 277():119-26. PubMed ID: 3141934
    [No Abstract]   [Full Text] [Related]  

  • 59. Intensity modulated radiation therapy safe, effective for prostate cancer.
    Duke Med Health News; 2007 Jan; 13(1):10. PubMed ID: 17299890
    [No Abstract]   [Full Text] [Related]  

  • 60. Prostatic sarcoma after conservative treatment with brachytherapy for low-risk prostate cancer.
    Domínguez A; Piulats JM; Suárez JF; Condom E; Castells M; Camps N; García Del Muro FX; Franco E
    Acta Oncol; 2013 Aug; 52(6):1215-6. PubMed ID: 23095143
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.